ARCHIVES

FDA Committee Okays High Dose Methotrexate, Mitxantrone In ANL; reverse Breast Cancer Vote

This article is from The Cancer Letter archive.

Vol. 13 No. 48 | December 11, 1987

Download PDF Visit The Full Archive

Related Articles

Protocol Amendments Required For 98 NCI-Sponsored Trials

October 8, 2010

Maryland’s Greenebaum Cancer Center Wins NCI Designation.

September 12, 2008

Ultrasound Reported Accurate in Screen For Prostate Cancer

April 25, 1986

Five NCAB members complete terms.

February 20, 2004

DCPC Bard Approves $10 Million In Concepts

October 2, 1987

Clinical Trials Approved By NCI CTEP During May

June 28, 2002